While one study showed that suppressing METTL14 with siRNA impaired colony formation and invasion of TNBC cells [42], two recent clinical investigations indicated that low expression of METTL14 in breast cancer tissue is associated with shorter survival time of patients and is an independent unfavorable indicator for TNBC [32, 33]. This evidence concerns the gene METTL14 and breast carcinoma.